A recombinant baculovirus expressing the M2 protein from influenza A/Ann Arbor/6/60 (H2N2) virus (AA60 virus) was constructed. The expressed M2 protein was recognized by a monoclonal antibody specific for the M2 protein and comigrated with the M2 protein from cells infected with AA60 virus on SDS-polyacrylamide gels. Immunofluorescence studies indicated that the expressed M2 protein was present on the surface of Spodoptera frugiperda (Sf9) cells infected with the recombinant baculovirus. Immunoassays using the expressed M2 protein were able to detect antibodies to the M2 protein in serum samples from humans and ferrets infected with influenza A viruses.
A recombinant baculovirus expressing the M2 protein from influenza A/Ann Arbor/6/60 (H2N2) virus (AA60 virus) was constructed. The expressed M2 protein was recognized by a monoclonal antibody specific for the M2 protein and comigrated with the M2 protein from cells infected with AA60 virus on SDS-polyacrylamide gels. Immunofluorescence studies indicated that the expressed M2 protein was present on the surface of Spodoptera frugiperda (Sf9) cells infected with the recombinant baculovirus. Immunoassays using the expressed M2 protein were able to detect antibodies to the M2 protein in serum samples from humans and ferrets infected with influenza A viruses.
RNA segment 7 of influenza A virus encodes the membrane protein, M 1, as well as an integral membrane protein, M2. The M2 protein (97 amino acids), which is unique to influenza type A viruses, is expressed abundantly at the surface of infected cells and is present in small quantities on the surface of mature virions Zebedee et al., 1985) . The M2 protein exists as a disulphide-linked homotetramer (Sugrue & Hay, 1991 ; Holsinger & Lamb, 1991) , and it has recently been demonstrated to function as a transmembrane ion channel (Pinto et al., 1992) . Late in infection, this activity serves to regulate the vesicular pH in the infected cell, and prevents the low pH-induced conformational change of the haemagglutinin molecule occurring during its maturation (Hay et al., 1986; Hay, 1989; Sugrue et al., 1990; Ciampor et al., 1992a, b; Steinhauer et al., 1992) . The M2 protein may also function early in the infection process by regulating the pH within the virion to facilitate uncoating (Skehel et al., 1977; Hay et al., 1986) . The transmembrane portion of M2 (amino acids 25 to 43) has been identified as the target of the antiviral drug amantadine, and a single amino acid change in this domain can result in a virus which is resistant to this drug (Belshe et al., 1988; Belshe & Hay, 1989) .
To study the structural, functional and immunological characteristics of the M2 protein in greater detail, the M2 gene of influenza A/Ann Arbor/6/60 (H2N2) virus (AA60 virus) was cloned and expressed in the baculovirus Autographa caliJornica nuclear polyhedrosis virus (AcMNPV). We describe the construction of the recombinant baculovirus and the use of the expressed M2 protein in an enzyme immunoassay (EIA) and Western blot assays to detect antibody to M2 protein in serum samples from ferrets and humans.
Since the M2 protein is translated from a spliced mRNA (Lamb & Choppin, 1981; Lamb & Lai, 1982) , it was necessary to amplify the M2 gene of AA60 virus from total cellular RNA purified from infected CV-1 cells (Cox et al., 1986) . Polymerase chain reaction (PCR) primers designed to initiate cDNA synthesis from viral mRNA and to generate unique BamHI and BglII sites at the termini of the PCR product were constructed. M2 cDNA was prepared in reactions containing l0 ~tg RNA, 2.5 x PCR buffer (10 x PCR buffer is: 500 mM-KC1, 100 mM-Tris-HC1 pH 8.3, 15 mM-MgC12, 0.1% gelatin; Perkin-Elmer Cetus), 20 ~tM-dNTP, 1 ~tg M2MC primer (5'GATCAGATCTTTACTCCAGCTCTAT 3'), 20 units pancreatic ribonuclease inhibitor and 20 units reverse transcriptase, and incubated at 42 °C for 40 min. For amplification, cDNA was added to a PCR mixture containing 1 ~tg M2 forward primer (M2F: 5' GATCGGATCCAAGATGAGTCTTCTA 3') and 20 units Taq polymerase. After 25 cycles, the PCR products were digested with BamHI and BglII, purified by agarose gel electrophoresis, and ligated to pAcYM1-B1 (Matsuura et al., 1987; Rota et al., 1990) . Plasmid DNA from pAcYM1-M2 was sequenced (Sanger et al., 1977) to verify that the M2 gene was in the correct orientation relative to the polyhedrin gene start site (Matsuura et al., 1987) . The gene was found to be inserted 66 bases downstream of the polyhedrin gene promoter site.
The recombinant baculovirus Bac-AM2 was generated as described by Summers & Smith (1986) and purified by three rounds of limiting dilution and two rounds of Lysates of Sf9 cells infected with Bac-AM2 were prepared in 10 mM-Tris-HCl pH 7.2, 1 mM-EDTA, 2% Triton X-100, 0.5 M-KC1 and subjected to electrophoresis on 20 % SDS-polyacrylamide gels containing 4 M-urea. Filters were incubated with MAb 14C-2 and bound antibody was detected by using 125I-Protein A and autoradiography. plaque purification (Rota et al., 1990) . M2 expression was detected by indirect immunofluorescent antibody assay (IFA) on acetone-fixed Spodoptera frugiperda (Sf9) cells using a monoclonal antibody (MAb) (14C-2) recognizing the N-terminal domain of the M2 protein (Zebedee et al., 1988 ) (a kind gift from R. Lamb). Bac-AM2-infected cells demonstrated intense perinuclear fluorescence when incubated with 14C-2. M2 protein was also detected on the surface of infected cells fixed with 2 % paraformaldehyde. Sf9 cells infected with wild-type AcMNPV gave little background fluorescence (Fig. 1) . Western blot analysis demonstrated that the M2 protein produced by Bac-AM2 and the M2 protein from lysates of cells infected with AA60 virus had identical electrophoretic mobilities and were both recognized by MAb 14C-2 (Fig. 2) . This MAb did not cross-react with lysates prepared from uninfected Sf9 cells or with lysates from Sf9 cells infected with a recombinant baculovirus expressing the influenza type A virus nucleoprotein (NP). Further study will be required to determine whether the other structural features of the authentic M2 protein, such as tetramerization (Sugrue & Hay, 1991 ; Holsinger & Lamb, 1991) and acylation (Veit et al., 1991) , are maintained in insect cells.
To detect the baculovirus-expressed M2 protein by Western blotting, approximately 200 to 300 lag of cell lysate protein had to be loaded onto the gel (Fig. 2) , indicating that the expression of M2 protein by the recombinant baculovirus was less efficient than that of influenza virus NP (Rota et al., 1990) . However, further experiments indicated that the production of M2 protein could be enhanced approximately 10-fold by the addition of amantadine to the culture medium (R. Black, unpublished results) and this modification was used in the production of antigen for the subsequent immunological assays.
Initially, serum samples from ferrets experimentally infected with influenza type A H1N1, H2N2 and H3N2 viruses were tested by Western blotting using lysates prepared from Sf9 cells infected with Bac-AM2. The results indicated that antibody to M2 protein was made in the ferrets following infection by each of the subtypes (results not shown).
To test for the presence of antibodies to M2 protein in paired serum samples from humans who had confirmed cases of influenza, an EIA was performed using the baculovirus-expressed M2 protein. To prepare antigen for use in EIA, infected Sf9 cells were harvested after 3 to 4 days incubation. The pelleted cells were incubated in distilled water for 30 rain before 50 lal of 10 x alkaline glycine (1 M-glycine in 1 M-NaC1, pH 10) was added. This mixture was sonicated and incubated at 37 °C for 30 min, and the cell debris was removed by centrifugation. The supernatants were diluted in carbonate buffer (pH 9"6) and used to coat polystyrene microtitre plates. Seventeen pairs of acute-and convalescent-phase serum specimens from adults with influenza A (H3N2) virus infections and five pairs of serum specimens from individuals with influenza B virus infections, as shown by conventional EIA, were selected. These serum samples were then tested by EIA for antibodies to baculovirusexpressed M2 protein, and influenza A and B virus NP (ANP and BNP). EIA was performed as described previously (Rota et al., 1990 ) and serum pairs which had a P/N (convalescent/acute) value >~ 2.0 were considered positive for a rise in antibody titre against M2 protein or NP. Increases in anti-M2 protein antibody titre were detected in only six of the 17 serum pairs from individuals infected with influenza type A virus, although 15 showed a detectable increase in anti-ANP antibody titre. None of the five serum pairs from individuals infected with influenza B virus showed detectable antibody to M2 protein or an increase in titre to ANP.
Western blot assay using the baculovirus-expressed M2 protein was more sensitive than EIA and was able to detect anti-M2 protein antibodies in 12 of the 17 convalescent-phase serum specimens (Fig. 3) . In contrast to Western blot analysis of serum pairs for antibody against the ANP (Rota et al., 1990) , residual antibody against M2 protein from previous influenza A virus infections was not detected in the acute-phase serum specimens (Fig. 3) . In addition to M2 protein monomers, the serum specimens appear to recognize M2 protein dimers present on the blot due to incomplete denaturation of the samples prior to electrophoresis.
Although the EIA lacked sensitivity, our combined EIA and Western blot data clearly indicate that antibodies to the M2 protein are made in response to infection with influenza A virus. Failure to detect an increase in anti-M2 protein antibody titre in all cases could be due either to the sensitivity of both the EIA and Western blot assay, or to the nature of the antibody response itself. Antibodies to M2 protein may not reach as high a titre or persist as long as antibodies to other structural proteins, such as the NP. Alternatively, antibodies to M2 protein may not be made in all influenza A virus infections.
The nature of the immune response to the M2 protein has not been studied extensively and the presence of antibodies to M2 protein following infection has not been reported previously. An anti-M2 protein antibody has been shown to be able to restrict virus growth in vitro (Zebedee & Lamb, 1988) and partially to protect passively immunized mice from infection with influenza virus (Treanor et al., 1990) . A cytotoxic T lymphocyte or uninfected Sf9 cells were subjected to SDS-PAGE and transferred to a nylon membrane. The membrane was cut into strips and incubated with serum samples from two patients with confirmed cases of influenza A. Lanes 1 to 4 show reactivity of acute-phase (lanes 1 and 2) and convalescent-phase (lanes 3 and 4) sera from patient 1 with either uninfected Sf9 cell lysates (lanes 2 and 4) or lysates from cells infected with Bac-M2 (lanes 1 and 3). Lanes 5 to 8 show the corresponding reactivity pattern for sera from patient 2. Bound antibody was detected by using 125I-Protein A and autoradiography.
response to M2 protein in humans has also been reported (Gotch et al., 1987) . The M2 protein from human influenza A virus strains is conserved relative to the other membrane-associated proteins (Ito et al., 1991) and is abundant on the surface of infected cells . Therefore, M2 protein may be an important component in the development of improved subunit vaccines for influenza. The ability to express the M2 protein using cloned DNA has provided the opportunity of studying its properties without the involvement of other influenza virus proteins, and should allow more detailed studies of the immune response to M2 protein and its possible role as an immunogen.
